Apidaecin-type peptides: Biodiversity, structure-function relationships and mode of action

Peptides

Volumn 27, Issue 9, 2006, Pages 2350-2359

  Li, Wei Fen ^a   Ma, Guo Xia ^a   Zhou, Xu Xia ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Action mechanism; Antibacterial activity; Apidaecins; Biodiversity; Structure function relationships

Indexed keywords

ALANYLASPARAGINYLARGINYLPROLYLVALYLTYROSYLISOLEUCYLPROLYLPROLYLPROLYL ARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; ANTIINFECTIVE AGENT; ASPARAGINYLARGINYLPROLYLTHREONYLTYROSYLVALYLPROLYLALANYLPROLYLARGINYL PROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; ASPARAGINYLARGINYLPROLYLTHREONYLTYROSYLVALYLPROLYLPROLYLPROLYLARGINYL PROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; ASPARAGINYLARGINYLPROLYLVALYLTYROSYLISOLEUCYLPROLYLPROLYLPROLYLARGINYL PROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; GLYCYLASPARAGINYLASPARAGINYLARGINYLPROLYLISOLEUCYLTYROSYLISOLEUCYLPROLYL GLUTAMINYLPROLYLARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; GLYCYLASPARAGINYLASPARAGINYLARGINYLPROLYLISOLEUCYLTYROSYLISOLEUCYLSERYL GLUTAMINYLPROLYLARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; GLYCYLASPARAGINYLASPARAGINYLARGINYLPROLYLVALYLTYROSYLISOLEUCYLPROLYL GLUTAMINYLPROLYLARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLISOLEUCINE; GLYCYLASPARAGINYLASPARAGINYLARGINYLPROLYLVALYLTYROSYLISOLEUCYLPROLYL GLUTAMINYLPROLYLARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; GLYCYLLYSYLPROLYLARGINYLPROLYLGLUTAMINYLGLUTAMINYLVALYLPROLYLPROLYLARGINYL PROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; GLYCYLLYSYLPROLYLASPARAGINYLARGINYLPROLYLARGINYLPROLYLALANYLPROLYL ISOLEUCYLGLUTAMINYLPROLYLARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; GLYCYLLYSYLPROLYLASPARAGINYLLYSYLPROLYLARGINYLPROLYLALANYLPROLYLISOLEUCYL LYSYLPROLYLARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; GLYCYLLYSYLPROLYLSERYLLYSYLPROLYLARGINYLPROLYLALANYLPROLYLISOLEUCYLLYSYL PROLYLARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; POLYPEPTIDE ANTIBIOTIC AGENT; RECOMBINANT PROTEIN; SERYLASPARAGINYLLYSYLPROLYLARGINYLPROLYLGLUTAMINYLGLUTAMINYLVALYLPROLYL PROLYLARGINYLPROLYLPROLYLHISTIDYLPROLYLARGINYLLEUCINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERICIDAL ACTIVITY; BINDING AFFINITY; CHEMICAL STRUCTURE; CORRELATION ANALYSIS; DRUG MECHANISM; GENE FUNCTION; GRAM NEGATIVE BACTERIUM; HUMAN; MICROBIAL DIVERSITY; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; INSECT PROTEINS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; HEXAPODA; NEGIBACTERIA;

EID: 33746910238     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.03.016     Document Type: Review

References (51)

1. Agerberth B., Lee J.Y., Bergman T., Carlquist M., Boman H.G., Mutt V., et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 202 (1991) 849-854
2. Benincasa M., Scocchi M., Podda E., Skerlavaj B., Dolzani L., and Gennaro R. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates. Peptides 25 (2004) 2055-2061
3. Bessalle R., Kapitkovsky A., Gorea A., Shalit I., and Fridkin M. All-d-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 274 (1990) 151-155
4. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13 (1995) 61-92
5. Boman H.G., Agerberth B., and Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61 (1993) 2978-2984
6. Breukink E., and de Kruijff B. The lantibiotic nisin, a special case or not?. Biochim Biophys Acta 1462 (1999) 223-234
7. Brewer D., and Lajoie G. Structure-based design of potent histatin analogues. Biochemistry 41 (2002) 5526-5536
8. Bu X., Wu X., Xie G., and Guo Z. Synthesis of tyrocidine A and its analogues by spontaneous cyclization in aqueous solution. Org Lett 4 (2002) 2893-2895
9. Bulet P., Dimarcq J.L., Hetru C., Lagueux M., Charlet M., Hegy G., et al. A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution. J Biol Chem 268 (1993) 14893-14897
10. Casteels P., Ampe C., Jacobs F., Vaeck M., and Tempst P. Apidaecins: antibacterial peptides from honeybees. EMBO J 8 (1989) 2387-2391
11. Casteels P., Romagnolo J., Castle M., Casteels-Josson K., Erdjument-Bromage H., and Tempst P. Biodiversity of apidaecin-type peptide antibiotics. Prospects of manipulating the antibacterial spectrum and combating acquired resistance. J Biol Chem 269 (1994) 26107-26115
12. Casteels-Josson K., Capaci T., Casteels P., and Tempst P. Apidaecin multipeptide precursor structure: a putative mechanism for amplification of the insect antibacterial response. EMBO J 12 (1993) 1569-1578
13. Castle M., Nazarian A., Yi S.S., and Tempst P. Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets. J Biol Chem 274 (1999) 32555-32564
14. de Vos W.M., Kuipers O.P., van der Meer J.R., and Siezen R.J. Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by Gram-positive bacteria. Mol Microbiol 17 (1995) 427-437
15. Epand R.M., and Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462 (1999) 11-28
16. Gennaro R., Zanetti M., Benincasa M., Podda E., and Miani M. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr Pharm Des 8 (2002) 763-778
17. Gennaro R., Skerlavaj B., and Romeo D. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun 57 (1989) 3142-3146
18. Gobbo M., Biondi L., Filira F., Gennaro R., Benincasa M., Scolaro B., et al. Antimicrobial peptides: synthesis and antibacterial activity of linear and cyclic drosocin and apidaecin 1b analogues. J Med Chem 45 (2002) 4494-4504
19. Grotenbreg G.M., Witte M.D., van Hoof P.A., Spalburg E., Reiss P., Noort D., et al. Synthesis and biological evaluation of gramicidin S dimers. Org Biomol Chem 3 (2005) 233-238
20. Hancock R.E. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1 (2001) 156-164
21. Hunter H.N., Demcoe A.R., Jenssen H., Gutteberg T.J., and Vogel H.J. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob Agents Chemother 49 (2005) 3387-3395
22. Imler J.L., and Bulet P. Antimicrobial peptides in Drosophila: structures, activities and gene regulation. Chem Immunol Allergy 86 (2005) 1-21
23. Jones D.E., and Bevins C.L. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 267 (1992) 23216-23225
24. Kay B.K., Williamson M.P., and Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 14 (2000) 231-241
25. Kragol G., Lovas S., Varadi G., Condie B.A., Hoffmann R., and Otvos Jr. L. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry 40 (2001) 3016-3026
26. Lehrer R.I., Lichtenstein A.K., and Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11 (1993) 105-128
27. Lugtenberg B., and van Alphen L. Molecular architecture and functioning of the outer membrane of Escherichia coli and other Gram-negative bacteria. Biochim Biophys Acta 737 (1983) 51-115
28. Mangoni M.L., Rinaldi A.C., Di Giulio A., Mignogna G., Bozzi A., Barra D., et al. Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur J Biochem 267 (2000) 1447-1454
29. Markossian K.A., Zamyatnin A.A., and Kurganov B.I. Antibacterial proline-rich oligopeptides and their target proteins. Biochemistry 69 (2004) 1082-1091
30. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1462 (1999) 1-10
31. Montville T.J., and Chen Y. Mechanistic action of pediocin and nisin: recent progress and unresolved questions. Appl Microbiol Biotechnol 50 (1998) 511-519
32. O'Brien-Simpson N.M., Dashper S.G., and Reynolds E.C. Histatin 5 is a substrate and not an inhibitor of the Arg- and Lys-specific proteinases of Porphyromonas gingivalis. Biochem Biophys Res Commun 250 (1998) 474-478
33. Ostberg N., and Kaznessis Y. Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity. Peptides 26 (2005) 197-206
34. Otvos Jr L, O I, Rogers ME, Consolvo PJ, Condie BA, Lovas S, et al. Interaction between heat shock proteins and antimicrobial peptides. Biochem. 2000;39:14150-9.
35. Otvos Jr. L. The short proline-rich antibacterial peptide family. Cell Mol Life Sci 59 (2002) 1138-1150
36. Park C.B., Kim H.S., and Kim S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244 (1998) 253-257
37. Schibli D.J., Epand R.F., Vogel H.J., and Epand R.M. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem Cell Biol 80 (2002) 667-677
38. Shi J., Ross C.R., Leto T.L., and Blecha F. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47phox. Proc Natl Acad Sci USA 93 (1996) 6014-6018
39. Sun C., Chen X.Z., Huan L.D., and Peng X.X. Fusion expression of a peptide antibiotic-apidaecin gene in Lactococcus lactis. Sheng Wu Gong Cheng Xue Bao 17 (2001) 20-23
40. Taguchi S., Maeno M., and Momose H. Extracellular production system of heterologous peptide driven by a secretory protease inhibitor of Streptomyces. Appl Microbiol Biotechnol 36 (1992) 749-753
41. Taguchi S., Nakagawa K., Maeno M., and Momose H. In vivo monitoring system for structure-function relationship analysis of the antibacterial peptide apidaecin. Appl Environ Microbiol 60 (1994) 3566-3572
42. Taguchi S., Ozaki A., Nakagawa K., and Momose H. Functional mapping of amino acid residues responsible for the antibacterial action of apidaecin. Appl Environ Microbiol 62 (1996) 4652-4655
43. Tomasinsig L., Scocchi M., Mettulio R., and Zanetti M. Genome-wide transcriptional profiling of the Escherichia coli response to a proline-rich antimicrobial peptide. Antimicrob Agents Chemother 48 (2004) 3260-3267
44. Tomasinsig L., Skerlavaj B., Papo N., Giabbai B., Shai Y., and Zanetti M. Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J Biol Chem 281 (2006) 383-391
45. Tsubery H., Ofek I., Cohen S., and Fridkin M. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of Gram-negative bacteria. J Med Chem 43 (2000) 3085-3092
46. van Wetering S., Tjabringa G.S., and Hiemstra P.S. Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells. J Leukoc Biol 77 (2005) 444-450
47. van't Hof W., Veerman E.C., Helmerhorst E.J., and Amerongen A.V. Antimicrobial peptides: properties and applicability. Biol Chem 382 (2001) 597-619
48. Williamson M.P. The structure and function of proline-rich regions in proteins. Biochem J 297 (1994) 249-260
49. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75 (2004) 39-48
50. Zhao C., Ganz T., and Lehrer R.I. Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39. FEBS Lett 376 (1995) 130-134
51. Zylicz M., LeBowitz J.H., McMacken R., and Georgopoulos C. The DnaK protein of Escherichia coli possesses an ATPase and autophosphorylating activity and is essential in an in vitro DNA replication system. Proc Natl Acad Sci USA 80 (1983) 6431-6435